Citi Reiterates Buy and PT of $73 on Johnson & Johnson

Citi reiterated its Buy rating on Johnson & Johnson JNJ. At the same time, the rating agency left its price target on the company's stock unchanged at $73. On JNJ lost 1.52% of its value to end the day at $63.43. Its shares rebounded in today's pre-market trading, rising 0.36% to stand around $63.66.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: ReiterationAnalyst RatingsCitiHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!